trial · primary record
Acalabrutinib
Ann Arbor Stage III Grade 1 Follicular Lymphoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2028-03-01 |
| Primary endpoint | Complete remission rate |
| Registry ID | NCT04404088 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:13.820Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04404088
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Acalabrutinib · approval
- Acalabrutinib · compound